Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic Reprogramming of T Cells by MSCs Rebalances Th17/Treg Axis to Attenuate Collagen-Induced Arthritis. | J Immunol Res | 2026 | 42260739 | PubTator, text mining | PubMed |
| Macrophage metabolic reprogramming in sepsis-associated acute lung injury: mechanisms and therapeutic strategies. | Front Immunol | 2026 | 42220522 | PubTator, text mining | PubMed |
| P38γ drives aerobic glycolysis in liver sinusoidal endothelial cells and regulates alcoholic liver disease via the PFKFB3 signaling pathway. | Mol Biol Rep | 2026 | 42201586 | PubTator, text mining | PubMed |
| Glycolytic reprogramming in endometriosis: molecular mechanisms, immune modulation, and non-hormonal therapeutic opportunities. | BMC Womens Health | 2026 | 42186039 | PubTator, text mining | PubMed |
| Norepinephrine promotes lung cancer cell progression via PFKFB3-promoted histone lactylation-mediated activation of the NF-κB signaling pathway. | Open Life Sci | 2026 | 42157854 | PubTator, text mining | PubMed |
| Adrenal-derived factors drive progression of sclerotic prostate cancer in bone. | Endocr Relat Cancer | 2026 | 42149634 | PubTator, text mining | PubMed |
| Txnip regulates glycolysis and tricarboxylic acid cycle balance to maintain bone homeostasis. | J Orthop Translat | 2026 | 42125243 | PubTator, text mining | PubMed |
| Novel regulatory SNPs that can be activated due to metformin treatment may orchestrate liver gluconeogenesis and add to the variability in AMPK-dependent mechanisms of metformin response. | Vavilovskii Zhurnal Genet Selektsii | 2026 | 42111789 | PubTator, text mining | PubMed |
| Pdcd4-Rictor Interaction Suppresses PFKFB3 to inhibit Tumorigenesis. | Res Sq | 2026 | 42078886 | PubTator, text mining | PubMed |
| Integrating single-cell RNA and bulk RNA sequencing data to identify prognostic genes associated with pyrimidine metabolism in triple-negative breast cancer by machine learning algorithm combinations. | Discov Oncol | 2026 | 42060238 | PubTator, text mining | PubMed |
| Resveratrol inhibits aerobic glycolysis and promotes cuproptosis in acute myeloid leukemia via the PI3K/AKT signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42056286 | PubTator, text mining | PubMed |
| Glycolysis as a central pathological axis in neurodegenerative diseases. | Rev Neurosci | 2026 | 42043421 | PubTator, text mining | PubMed |
| Integrating bulk, single-cell, and spatial transcriptomics to identify a novel pyroptosis-related gene signature for predicting prognosis and tumor immune landscape in triple-negative breast cancer. | Front Immunol | 2026 | 42023218 | PubTator, text mining | PubMed |
| Vitamin D attenuates the progression of pulmonary fibrosis via inhibiting thymidine kinase 1/PFKFB3-driven glycolysis. | J Transl Med | 2026 | 42021376 | PubTator, text mining | PubMed |
| From inflammation to malignancy: the dynamic evolution of cancer-associated fibroblasts in IBD-CRC. | Neoplasia | 2026 | 42019096 | PubTator, text mining | PubMed |
| Glucose metabolic reprogramming in systemic lupus erythematosus and lupus nephritis: theoretical foundations and therapeutic implications. | Front Immunol | 2026 | 42004957 | PubTator, text mining | PubMed |
| 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3: A potential target in the development of diabetes and its complications. | Metabolism | 2026 | 41990915 | PubTator, text mining | PubMed |
| PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth. | Cell Rep | 2026 | 41989915 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| Purification and characterisation of human heart recombinant PFK-2/FBPase-2 and evaluation of its possible inhibitors for the FBPase-2 domain. | Int J Biol Macromol | 2026 | 41911995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=3